Global Adult Vaccines Supply, Demand and Key Producers, 2023-2029
The global Adult Vaccines market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Adult Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Adult Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adult Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Adult Vaccines total production and demand, 2018-2029, (K Units)
Global Adult Vaccines total production value, 2018-2029, (USD Million)
Global Adult Vaccines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adult Vaccines consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Adult Vaccines domestic production, consumption, key domestic manufacturers and share
Global Adult Vaccines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Adult Vaccines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adult Vaccines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Adult Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Solvay Pharmaceuticals, Moderna, BioCSL (Seqirus), Aventis Pasteur, Sanofi Pasteur, Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline Plc and Novartis AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adult Vaccines market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Adult Vaccines Market, By Region:
1. How big is the global Adult Vaccines market?
2. What is the demand of the global Adult Vaccines market?
3. What is the year over year growth of the global Adult Vaccines market?
4. What is the production and production value of the global Adult Vaccines market?
5. Who are the key producers in the global Adult Vaccines market?
This report studies the global Adult Vaccines production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Adult Vaccines, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Adult Vaccines that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Adult Vaccines total production and demand, 2018-2029, (K Units)
Global Adult Vaccines total production value, 2018-2029, (USD Million)
Global Adult Vaccines production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adult Vaccines consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Adult Vaccines domestic production, consumption, key domestic manufacturers and share
Global Adult Vaccines production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Adult Vaccines production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Adult Vaccines production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).
This reports profiles key players in the global Adult Vaccines market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Solvay Pharmaceuticals, Moderna, BioCSL (Seqirus), Aventis Pasteur, Sanofi Pasteur, Pfizer Inc., Merck & Co. Inc., GlaxoSmithKline Plc and Novartis AG, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Adult Vaccines market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Adult Vaccines Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Monovalent Vaccines
- Multivalent Vaccines
- Private Healthcare Firms
- Government Hospitals
- Solvay Pharmaceuticals
- Moderna
- BioCSL (Seqirus)
- Aventis Pasteur
- Sanofi Pasteur
- Pfizer Inc.
- Merck & Co. Inc.
- GlaxoSmithKline Plc
- Novartis AG
- Johnson & Johnson
- BioNTech
- Bharat Biotech International Limited
- Zhifei
- Wyeth Vaccines
- AstraZeneca Plc
- Medimmune
- Sinovac
- Baxter International Healthcare Company
- Chiron Vaccines
- Serum Institute of India.
1. How big is the global Adult Vaccines market?
2. What is the demand of the global Adult Vaccines market?
3. What is the year over year growth of the global Adult Vaccines market?
4. What is the production and production value of the global Adult Vaccines market?
5. Who are the key producers in the global Adult Vaccines market?
1 SUPPLY SUMMARY
1.1 Adult Vaccines Introduction
1.2 World Adult Vaccines Supply & Forecast
1.2.1 World Adult Vaccines Production Value (2018 & 2022 & 2029)
1.2.2 World Adult Vaccines Production (2018-2029)
1.2.3 World Adult Vaccines Pricing Trends (2018-2029)
1.3 World Adult Vaccines Production by Region (Based on Production Site)
1.3.1 World Adult Vaccines Production Value by Region (2018-2029)
1.3.2 World Adult Vaccines Production by Region (2018-2029)
1.3.3 World Adult Vaccines Average Price by Region (2018-2029)
1.3.4 North America Adult Vaccines Production (2018-2029)
1.3.5 Europe Adult Vaccines Production (2018-2029)
1.3.6 China Adult Vaccines Production (2018-2029)
1.3.7 Japan Adult Vaccines Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Adult Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Adult Vaccines Major Market Trends
2 DEMAND SUMMARY
2.1 World Adult Vaccines Demand (2018-2029)
2.2 World Adult Vaccines Consumption by Region
2.2.1 World Adult Vaccines Consumption by Region (2018-2023)
2.2.2 World Adult Vaccines Consumption Forecast by Region (2024-2029)
2.3 United States Adult Vaccines Consumption (2018-2029)
2.4 China Adult Vaccines Consumption (2018-2029)
2.5 Europe Adult Vaccines Consumption (2018-2029)
2.6 Japan Adult Vaccines Consumption (2018-2029)
2.7 South Korea Adult Vaccines Consumption (2018-2029)
2.8 ASEAN Adult Vaccines Consumption (2018-2029)
2.9 India Adult Vaccines Consumption (2018-2029)
3 WORLD ADULT VACCINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Adult Vaccines Production Value by Manufacturer (2018-2023)
3.2 World Adult Vaccines Production by Manufacturer (2018-2023)
3.3 World Adult Vaccines Average Price by Manufacturer (2018-2023)
3.4 Adult Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Adult Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Adult Vaccines in 2022
3.5.3 Global Concentration Ratios (CR8) for Adult Vaccines in 2022
3.6 Adult Vaccines Market: Overall Company Footprint Analysis
3.6.1 Adult Vaccines Market: Region Footprint
3.6.2 Adult Vaccines Market: Company Product Type Footprint
3.6.3 Adult Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Adult Vaccines Production Value Comparison
4.1.1 United States VS China: Adult Vaccines Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Adult Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Adult Vaccines Production Comparison
4.2.1 United States VS China: Adult Vaccines Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Adult Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Adult Vaccines Consumption Comparison
4.3.1 United States VS China: Adult Vaccines Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Adult Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Adult Vaccines Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Adult Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Adult Vaccines Production Value (2018-2023)
4.4.3 United States Based Manufacturers Adult Vaccines Production (2018-2023)
4.5 China Based Adult Vaccines Manufacturers and Market Share
4.5.1 China Based Adult Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Adult Vaccines Production Value (2018-2023)
4.5.3 China Based Manufacturers Adult Vaccines Production (2018-2023)
4.6 Rest of World Based Adult Vaccines Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Adult Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Adult Vaccines Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Adult Vaccines Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Adult Vaccines Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monovalent Vaccines
5.2.2 Multivalent Vaccines
5.3 Market Segment by Type
5.3.1 World Adult Vaccines Production by Type (2018-2029)
5.3.2 World Adult Vaccines Production Value by Type (2018-2029)
5.3.3 World Adult Vaccines Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Adult Vaccines Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Private Healthcare Firms
6.2.2 Government Hospitals
6.3 Market Segment by Application
6.3.1 World Adult Vaccines Production by Application (2018-2029)
6.3.2 World Adult Vaccines Production Value by Application (2018-2029)
6.3.3 World Adult Vaccines Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Solvay Pharmaceuticals
7.1.1 Solvay Pharmaceuticals Details
7.1.2 Solvay Pharmaceuticals Major Business
7.1.3 Solvay Pharmaceuticals Adult Vaccines Product and Services
7.1.4 Solvay Pharmaceuticals Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Solvay Pharmaceuticals Recent Developments/Updates
7.1.6 Solvay Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Moderna
7.2.1 Moderna Details
7.2.2 Moderna Major Business
7.2.3 Moderna Adult Vaccines Product and Services
7.2.4 Moderna Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Moderna Recent Developments/Updates
7.2.6 Moderna Competitive Strengths & Weaknesses
7.3 BioCSL (Seqirus)
7.3.1 BioCSL (Seqirus) Details
7.3.2 BioCSL (Seqirus) Major Business
7.3.3 BioCSL (Seqirus) Adult Vaccines Product and Services
7.3.4 BioCSL (Seqirus) Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 BioCSL (Seqirus) Recent Developments/Updates
7.3.6 BioCSL (Seqirus) Competitive Strengths & Weaknesses
7.4 Aventis Pasteur
7.4.1 Aventis Pasteur Details
7.4.2 Aventis Pasteur Major Business
7.4.3 Aventis Pasteur Adult Vaccines Product and Services
7.4.4 Aventis Pasteur Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Aventis Pasteur Recent Developments/Updates
7.4.6 Aventis Pasteur Competitive Strengths & Weaknesses
7.5 Sanofi Pasteur
7.5.1 Sanofi Pasteur Details
7.5.2 Sanofi Pasteur Major Business
7.5.3 Sanofi Pasteur Adult Vaccines Product and Services
7.5.4 Sanofi Pasteur Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Pasteur Recent Developments/Updates
7.5.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Details
7.6.2 Pfizer Inc. Major Business
7.6.3 Pfizer Inc. Adult Vaccines Product and Services
7.6.4 Pfizer Inc. Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer Inc. Recent Developments/Updates
7.6.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.7 Merck & Co. Inc.
7.7.1 Merck & Co. Inc. Details
7.7.2 Merck & Co. Inc. Major Business
7.7.3 Merck & Co. Inc. Adult Vaccines Product and Services
7.7.4 Merck & Co. Inc. Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck & Co. Inc. Recent Developments/Updates
7.7.6 Merck & Co. Inc. Competitive Strengths & Weaknesses
7.8 GlaxoSmithKline Plc
7.8.1 GlaxoSmithKline Plc Details
7.8.2 GlaxoSmithKline Plc Major Business
7.8.3 GlaxoSmithKline Plc Adult Vaccines Product and Services
7.8.4 GlaxoSmithKline Plc Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 GlaxoSmithKline Plc Recent Developments/Updates
7.8.6 GlaxoSmithKline Plc Competitive Strengths & Weaknesses
7.9 Novartis AG
7.9.1 Novartis AG Details
7.9.2 Novartis AG Major Business
7.9.3 Novartis AG Adult Vaccines Product and Services
7.9.4 Novartis AG Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Novartis AG Recent Developments/Updates
7.9.6 Novartis AG Competitive Strengths & Weaknesses
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Details
7.10.2 Johnson & Johnson Major Business
7.10.3 Johnson & Johnson Adult Vaccines Product and Services
7.10.4 Johnson & Johnson Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Johnson & Johnson Recent Developments/Updates
7.10.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.11 BioNTech
7.11.1 BioNTech Details
7.11.2 BioNTech Major Business
7.11.3 BioNTech Adult Vaccines Product and Services
7.11.4 BioNTech Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 BioNTech Recent Developments/Updates
7.11.6 BioNTech Competitive Strengths & Weaknesses
7.12 Bharat Biotech International Limited
7.12.1 Bharat Biotech International Limited Details
7.12.2 Bharat Biotech International Limited Major Business
7.12.3 Bharat Biotech International Limited Adult Vaccines Product and Services
7.12.4 Bharat Biotech International Limited Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Bharat Biotech International Limited Recent Developments/Updates
7.12.6 Bharat Biotech International Limited Competitive Strengths & Weaknesses
7.13 Zhifei
7.13.1 Zhifei Details
7.13.2 Zhifei Major Business
7.13.3 Zhifei Adult Vaccines Product and Services
7.13.4 Zhifei Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Zhifei Recent Developments/Updates
7.13.6 Zhifei Competitive Strengths & Weaknesses
7.14 Wyeth Vaccines
7.14.1 Wyeth Vaccines Details
7.14.2 Wyeth Vaccines Major Business
7.14.3 Wyeth Vaccines Adult Vaccines Product and Services
7.14.4 Wyeth Vaccines Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Wyeth Vaccines Recent Developments/Updates
7.14.6 Wyeth Vaccines Competitive Strengths & Weaknesses
7.15 AstraZeneca Plc
7.15.1 AstraZeneca Plc Details
7.15.2 AstraZeneca Plc Major Business
7.15.3 AstraZeneca Plc Adult Vaccines Product and Services
7.15.4 AstraZeneca Plc Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 AstraZeneca Plc Recent Developments/Updates
7.15.6 AstraZeneca Plc Competitive Strengths & Weaknesses
7.16 Medimmune
7.16.1 Medimmune Details
7.16.2 Medimmune Major Business
7.16.3 Medimmune Adult Vaccines Product and Services
7.16.4 Medimmune Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Medimmune Recent Developments/Updates
7.16.6 Medimmune Competitive Strengths & Weaknesses
7.17 Sinovac
7.17.1 Sinovac Details
7.17.2 Sinovac Major Business
7.17.3 Sinovac Adult Vaccines Product and Services
7.17.4 Sinovac Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Sinovac Recent Developments/Updates
7.17.6 Sinovac Competitive Strengths & Weaknesses
7.18 Baxter International Healthcare Company
7.18.1 Baxter International Healthcare Company Details
7.18.2 Baxter International Healthcare Company Major Business
7.18.3 Baxter International Healthcare Company Adult Vaccines Product and Services
7.18.4 Baxter International Healthcare Company Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Baxter International Healthcare Company Recent Developments/Updates
7.18.6 Baxter International Healthcare Company Competitive Strengths & Weaknesses
7.19 Chiron Vaccines
7.19.1 Chiron Vaccines Details
7.19.2 Chiron Vaccines Major Business
7.19.3 Chiron Vaccines Adult Vaccines Product and Services
7.19.4 Chiron Vaccines Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Chiron Vaccines Recent Developments/Updates
7.19.6 Chiron Vaccines Competitive Strengths & Weaknesses
7.20 Serum Institute of India.
7.20.1 Serum Institute of India. Details
7.20.2 Serum Institute of India. Major Business
7.20.3 Serum Institute of India. Adult Vaccines Product and Services
7.20.4 Serum Institute of India. Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Serum Institute of India. Recent Developments/Updates
7.20.6 Serum Institute of India. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Adult Vaccines Industry Chain
8.2 Adult Vaccines Upstream Analysis
8.2.1 Adult Vaccines Core Raw Materials
8.2.2 Main Manufacturers of Adult Vaccines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Adult Vaccines Production Mode
8.6 Adult Vaccines Procurement Model
8.7 Adult Vaccines Industry Sales Model and Sales Channels
8.7.1 Adult Vaccines Sales Model
8.7.2 Adult Vaccines Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Adult Vaccines Introduction
1.2 World Adult Vaccines Supply & Forecast
1.2.1 World Adult Vaccines Production Value (2018 & 2022 & 2029)
1.2.2 World Adult Vaccines Production (2018-2029)
1.2.3 World Adult Vaccines Pricing Trends (2018-2029)
1.3 World Adult Vaccines Production by Region (Based on Production Site)
1.3.1 World Adult Vaccines Production Value by Region (2018-2029)
1.3.2 World Adult Vaccines Production by Region (2018-2029)
1.3.3 World Adult Vaccines Average Price by Region (2018-2029)
1.3.4 North America Adult Vaccines Production (2018-2029)
1.3.5 Europe Adult Vaccines Production (2018-2029)
1.3.6 China Adult Vaccines Production (2018-2029)
1.3.7 Japan Adult Vaccines Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Adult Vaccines Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Adult Vaccines Major Market Trends
2 DEMAND SUMMARY
2.1 World Adult Vaccines Demand (2018-2029)
2.2 World Adult Vaccines Consumption by Region
2.2.1 World Adult Vaccines Consumption by Region (2018-2023)
2.2.2 World Adult Vaccines Consumption Forecast by Region (2024-2029)
2.3 United States Adult Vaccines Consumption (2018-2029)
2.4 China Adult Vaccines Consumption (2018-2029)
2.5 Europe Adult Vaccines Consumption (2018-2029)
2.6 Japan Adult Vaccines Consumption (2018-2029)
2.7 South Korea Adult Vaccines Consumption (2018-2029)
2.8 ASEAN Adult Vaccines Consumption (2018-2029)
2.9 India Adult Vaccines Consumption (2018-2029)
3 WORLD ADULT VACCINES MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Adult Vaccines Production Value by Manufacturer (2018-2023)
3.2 World Adult Vaccines Production by Manufacturer (2018-2023)
3.3 World Adult Vaccines Average Price by Manufacturer (2018-2023)
3.4 Adult Vaccines Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Adult Vaccines Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Adult Vaccines in 2022
3.5.3 Global Concentration Ratios (CR8) for Adult Vaccines in 2022
3.6 Adult Vaccines Market: Overall Company Footprint Analysis
3.6.1 Adult Vaccines Market: Region Footprint
3.6.2 Adult Vaccines Market: Company Product Type Footprint
3.6.3 Adult Vaccines Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Adult Vaccines Production Value Comparison
4.1.1 United States VS China: Adult Vaccines Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Adult Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Adult Vaccines Production Comparison
4.2.1 United States VS China: Adult Vaccines Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Adult Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Adult Vaccines Consumption Comparison
4.3.1 United States VS China: Adult Vaccines Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Adult Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Adult Vaccines Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Adult Vaccines Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Adult Vaccines Production Value (2018-2023)
4.4.3 United States Based Manufacturers Adult Vaccines Production (2018-2023)
4.5 China Based Adult Vaccines Manufacturers and Market Share
4.5.1 China Based Adult Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Adult Vaccines Production Value (2018-2023)
4.5.3 China Based Manufacturers Adult Vaccines Production (2018-2023)
4.6 Rest of World Based Adult Vaccines Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Adult Vaccines Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Adult Vaccines Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Adult Vaccines Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Adult Vaccines Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Monovalent Vaccines
5.2.2 Multivalent Vaccines
5.3 Market Segment by Type
5.3.1 World Adult Vaccines Production by Type (2018-2029)
5.3.2 World Adult Vaccines Production Value by Type (2018-2029)
5.3.3 World Adult Vaccines Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Adult Vaccines Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Private Healthcare Firms
6.2.2 Government Hospitals
6.3 Market Segment by Application
6.3.1 World Adult Vaccines Production by Application (2018-2029)
6.3.2 World Adult Vaccines Production Value by Application (2018-2029)
6.3.3 World Adult Vaccines Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Solvay Pharmaceuticals
7.1.1 Solvay Pharmaceuticals Details
7.1.2 Solvay Pharmaceuticals Major Business
7.1.3 Solvay Pharmaceuticals Adult Vaccines Product and Services
7.1.4 Solvay Pharmaceuticals Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Solvay Pharmaceuticals Recent Developments/Updates
7.1.6 Solvay Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Moderna
7.2.1 Moderna Details
7.2.2 Moderna Major Business
7.2.3 Moderna Adult Vaccines Product and Services
7.2.4 Moderna Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Moderna Recent Developments/Updates
7.2.6 Moderna Competitive Strengths & Weaknesses
7.3 BioCSL (Seqirus)
7.3.1 BioCSL (Seqirus) Details
7.3.2 BioCSL (Seqirus) Major Business
7.3.3 BioCSL (Seqirus) Adult Vaccines Product and Services
7.3.4 BioCSL (Seqirus) Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 BioCSL (Seqirus) Recent Developments/Updates
7.3.6 BioCSL (Seqirus) Competitive Strengths & Weaknesses
7.4 Aventis Pasteur
7.4.1 Aventis Pasteur Details
7.4.2 Aventis Pasteur Major Business
7.4.3 Aventis Pasteur Adult Vaccines Product and Services
7.4.4 Aventis Pasteur Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Aventis Pasteur Recent Developments/Updates
7.4.6 Aventis Pasteur Competitive Strengths & Weaknesses
7.5 Sanofi Pasteur
7.5.1 Sanofi Pasteur Details
7.5.2 Sanofi Pasteur Major Business
7.5.3 Sanofi Pasteur Adult Vaccines Product and Services
7.5.4 Sanofi Pasteur Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Sanofi Pasteur Recent Developments/Updates
7.5.6 Sanofi Pasteur Competitive Strengths & Weaknesses
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Details
7.6.2 Pfizer Inc. Major Business
7.6.3 Pfizer Inc. Adult Vaccines Product and Services
7.6.4 Pfizer Inc. Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Pfizer Inc. Recent Developments/Updates
7.6.6 Pfizer Inc. Competitive Strengths & Weaknesses
7.7 Merck & Co. Inc.
7.7.1 Merck & Co. Inc. Details
7.7.2 Merck & Co. Inc. Major Business
7.7.3 Merck & Co. Inc. Adult Vaccines Product and Services
7.7.4 Merck & Co. Inc. Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck & Co. Inc. Recent Developments/Updates
7.7.6 Merck & Co. Inc. Competitive Strengths & Weaknesses
7.8 GlaxoSmithKline Plc
7.8.1 GlaxoSmithKline Plc Details
7.8.2 GlaxoSmithKline Plc Major Business
7.8.3 GlaxoSmithKline Plc Adult Vaccines Product and Services
7.8.4 GlaxoSmithKline Plc Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 GlaxoSmithKline Plc Recent Developments/Updates
7.8.6 GlaxoSmithKline Plc Competitive Strengths & Weaknesses
7.9 Novartis AG
7.9.1 Novartis AG Details
7.9.2 Novartis AG Major Business
7.9.3 Novartis AG Adult Vaccines Product and Services
7.9.4 Novartis AG Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Novartis AG Recent Developments/Updates
7.9.6 Novartis AG Competitive Strengths & Weaknesses
7.10 Johnson & Johnson
7.10.1 Johnson & Johnson Details
7.10.2 Johnson & Johnson Major Business
7.10.3 Johnson & Johnson Adult Vaccines Product and Services
7.10.4 Johnson & Johnson Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Johnson & Johnson Recent Developments/Updates
7.10.6 Johnson & Johnson Competitive Strengths & Weaknesses
7.11 BioNTech
7.11.1 BioNTech Details
7.11.2 BioNTech Major Business
7.11.3 BioNTech Adult Vaccines Product and Services
7.11.4 BioNTech Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 BioNTech Recent Developments/Updates
7.11.6 BioNTech Competitive Strengths & Weaknesses
7.12 Bharat Biotech International Limited
7.12.1 Bharat Biotech International Limited Details
7.12.2 Bharat Biotech International Limited Major Business
7.12.3 Bharat Biotech International Limited Adult Vaccines Product and Services
7.12.4 Bharat Biotech International Limited Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 Bharat Biotech International Limited Recent Developments/Updates
7.12.6 Bharat Biotech International Limited Competitive Strengths & Weaknesses
7.13 Zhifei
7.13.1 Zhifei Details
7.13.2 Zhifei Major Business
7.13.3 Zhifei Adult Vaccines Product and Services
7.13.4 Zhifei Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Zhifei Recent Developments/Updates
7.13.6 Zhifei Competitive Strengths & Weaknesses
7.14 Wyeth Vaccines
7.14.1 Wyeth Vaccines Details
7.14.2 Wyeth Vaccines Major Business
7.14.3 Wyeth Vaccines Adult Vaccines Product and Services
7.14.4 Wyeth Vaccines Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Wyeth Vaccines Recent Developments/Updates
7.14.6 Wyeth Vaccines Competitive Strengths & Weaknesses
7.15 AstraZeneca Plc
7.15.1 AstraZeneca Plc Details
7.15.2 AstraZeneca Plc Major Business
7.15.3 AstraZeneca Plc Adult Vaccines Product and Services
7.15.4 AstraZeneca Plc Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 AstraZeneca Plc Recent Developments/Updates
7.15.6 AstraZeneca Plc Competitive Strengths & Weaknesses
7.16 Medimmune
7.16.1 Medimmune Details
7.16.2 Medimmune Major Business
7.16.3 Medimmune Adult Vaccines Product and Services
7.16.4 Medimmune Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Medimmune Recent Developments/Updates
7.16.6 Medimmune Competitive Strengths & Weaknesses
7.17 Sinovac
7.17.1 Sinovac Details
7.17.2 Sinovac Major Business
7.17.3 Sinovac Adult Vaccines Product and Services
7.17.4 Sinovac Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 Sinovac Recent Developments/Updates
7.17.6 Sinovac Competitive Strengths & Weaknesses
7.18 Baxter International Healthcare Company
7.18.1 Baxter International Healthcare Company Details
7.18.2 Baxter International Healthcare Company Major Business
7.18.3 Baxter International Healthcare Company Adult Vaccines Product and Services
7.18.4 Baxter International Healthcare Company Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 Baxter International Healthcare Company Recent Developments/Updates
7.18.6 Baxter International Healthcare Company Competitive Strengths & Weaknesses
7.19 Chiron Vaccines
7.19.1 Chiron Vaccines Details
7.19.2 Chiron Vaccines Major Business
7.19.3 Chiron Vaccines Adult Vaccines Product and Services
7.19.4 Chiron Vaccines Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Chiron Vaccines Recent Developments/Updates
7.19.6 Chiron Vaccines Competitive Strengths & Weaknesses
7.20 Serum Institute of India.
7.20.1 Serum Institute of India. Details
7.20.2 Serum Institute of India. Major Business
7.20.3 Serum Institute of India. Adult Vaccines Product and Services
7.20.4 Serum Institute of India. Adult Vaccines Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Serum Institute of India. Recent Developments/Updates
7.20.6 Serum Institute of India. Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Adult Vaccines Industry Chain
8.2 Adult Vaccines Upstream Analysis
8.2.1 Adult Vaccines Core Raw Materials
8.2.2 Main Manufacturers of Adult Vaccines Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Adult Vaccines Production Mode
8.6 Adult Vaccines Procurement Model
8.7 Adult Vaccines Industry Sales Model and Sales Channels
8.7.1 Adult Vaccines Sales Model
8.7.2 Adult Vaccines Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Adult Vaccines Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Adult Vaccines Production Value by Region (2018-2023) & (USD Million)
Table 3. World Adult Vaccines Production Value by Region (2024-2029) & (USD Million)
Table 4. World Adult Vaccines Production Value Market Share by Region (2018-2023)
Table 5. World Adult Vaccines Production Value Market Share by Region (2024-2029)
Table 6. World Adult Vaccines Production by Region (2018-2023) & (K Units)
Table 7. World Adult Vaccines Production by Region (2024-2029) & (K Units)
Table 8. World Adult Vaccines Production Market Share by Region (2018-2023)
Table 9. World Adult Vaccines Production Market Share by Region (2024-2029)
Table 10. World Adult Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Adult Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Adult Vaccines Major Market Trends
Table 13. World Adult Vaccines Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Adult Vaccines Consumption by Region (2018-2023) & (K Units)
Table 15. World Adult Vaccines Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Adult Vaccines Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Adult Vaccines Producers in 2022
Table 18. World Adult Vaccines Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Adult Vaccines Producers in 2022
Table 20. World Adult Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Adult Vaccines Company Evaluation Quadrant
Table 22. World Adult Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Adult Vaccines Production Site of Key Manufacturer
Table 24. Adult Vaccines Market: Company Product Type Footprint
Table 25. Adult Vaccines Market: Company Product Application Footprint
Table 26. Adult Vaccines Competitive Factors
Table 27. Adult Vaccines New Entrant and Capacity Expansion Plans
Table 28. Adult Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Adult Vaccines Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Adult Vaccines Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Adult Vaccines Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Adult Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Adult Vaccines Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Adult Vaccines Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Adult Vaccines Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Adult Vaccines Production Market Share (2018-2023)
Table 37. China Based Adult Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Adult Vaccines Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Adult Vaccines Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Adult Vaccines Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Adult Vaccines Production Market Share (2018-2023)
Table 42. Rest of World Based Adult Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Adult Vaccines Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Adult Vaccines Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Adult Vaccines Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Adult Vaccines Production Market Share (2018-2023)
Table 47. World Adult Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Adult Vaccines Production by Type (2018-2023) & (K Units)
Table 49. World Adult Vaccines Production by Type (2024-2029) & (K Units)
Table 50. World Adult Vaccines Production Value by Type (2018-2023) & (USD Million)
Table 51. World Adult Vaccines Production Value by Type (2024-2029) & (USD Million)
Table 52. World Adult Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Adult Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Adult Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Adult Vaccines Production by Application (2018-2023) & (K Units)
Table 56. World Adult Vaccines Production by Application (2024-2029) & (K Units)
Table 57. World Adult Vaccines Production Value by Application (2018-2023) & (USD Million)
Table 58. World Adult Vaccines Production Value by Application (2024-2029) & (USD Million)
Table 59. World Adult Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Adult Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Solvay Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Solvay Pharmaceuticals Major Business
Table 63. Solvay Pharmaceuticals Adult Vaccines Product and Services
Table 64. Solvay Pharmaceuticals Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Solvay Pharmaceuticals Recent Developments/Updates
Table 66. Solvay Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Moderna Basic Information, Manufacturing Base and Competitors
Table 68. Moderna Major Business
Table 69. Moderna Adult Vaccines Product and Services
Table 70. Moderna Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Moderna Recent Developments/Updates
Table 72. Moderna Competitive Strengths & Weaknesses
Table 73. BioCSL (Seqirus) Basic Information, Manufacturing Base and Competitors
Table 74. BioCSL (Seqirus) Major Business
Table 75. BioCSL (Seqirus) Adult Vaccines Product and Services
Table 76. BioCSL (Seqirus) Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. BioCSL (Seqirus) Recent Developments/Updates
Table 78. BioCSL (Seqirus) Competitive Strengths & Weaknesses
Table 79. Aventis Pasteur Basic Information, Manufacturing Base and Competitors
Table 80. Aventis Pasteur Major Business
Table 81. Aventis Pasteur Adult Vaccines Product and Services
Table 82. Aventis Pasteur Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Aventis Pasteur Recent Developments/Updates
Table 84. Aventis Pasteur Competitive Strengths & Weaknesses
Table 85. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Pasteur Major Business
Table 87. Sanofi Pasteur Adult Vaccines Product and Services
Table 88. Sanofi Pasteur Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Pasteur Recent Developments/Updates
Table 90. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 91. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer Inc. Major Business
Table 93. Pfizer Inc. Adult Vaccines Product and Services
Table 94. Pfizer Inc. Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Pfizer Inc. Recent Developments/Updates
Table 96. Pfizer Inc. Competitive Strengths & Weaknesses
Table 97. Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Merck & Co. Inc. Major Business
Table 99. Merck & Co. Inc. Adult Vaccines Product and Services
Table 100. Merck & Co. Inc. Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck & Co. Inc. Recent Developments/Updates
Table 102. Merck & Co. Inc. Competitive Strengths & Weaknesses
Table 103. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 104. GlaxoSmithKline Plc Major Business
Table 105. GlaxoSmithKline Plc Adult Vaccines Product and Services
Table 106. GlaxoSmithKline Plc Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. GlaxoSmithKline Plc Recent Developments/Updates
Table 108. GlaxoSmithKline Plc Competitive Strengths & Weaknesses
Table 109. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 110. Novartis AG Major Business
Table 111. Novartis AG Adult Vaccines Product and Services
Table 112. Novartis AG Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Novartis AG Recent Developments/Updates
Table 114. Novartis AG Competitive Strengths & Weaknesses
Table 115. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 116. Johnson & Johnson Major Business
Table 117. Johnson & Johnson Adult Vaccines Product and Services
Table 118. Johnson & Johnson Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Johnson & Johnson Recent Developments/Updates
Table 120. Johnson & Johnson Competitive Strengths & Weaknesses
Table 121. BioNTech Basic Information, Manufacturing Base and Competitors
Table 122. BioNTech Major Business
Table 123. BioNTech Adult Vaccines Product and Services
Table 124. BioNTech Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. BioNTech Recent Developments/Updates
Table 126. BioNTech Competitive Strengths & Weaknesses
Table 127. Bharat Biotech International Limited Basic Information, Manufacturing Base and Competitors
Table 128. Bharat Biotech International Limited Major Business
Table 129. Bharat Biotech International Limited Adult Vaccines Product and Services
Table 130. Bharat Biotech International Limited Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Bharat Biotech International Limited Recent Developments/Updates
Table 132. Bharat Biotech International Limited Competitive Strengths & Weaknesses
Table 133. Zhifei Basic Information, Manufacturing Base and Competitors
Table 134. Zhifei Major Business
Table 135. Zhifei Adult Vaccines Product and Services
Table 136. Zhifei Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Zhifei Recent Developments/Updates
Table 138. Zhifei Competitive Strengths & Weaknesses
Table 139. Wyeth Vaccines Basic Information, Manufacturing Base and Competitors
Table 140. Wyeth Vaccines Major Business
Table 141. Wyeth Vaccines Adult Vaccines Product and Services
Table 142. Wyeth Vaccines Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Wyeth Vaccines Recent Developments/Updates
Table 144. Wyeth Vaccines Competitive Strengths & Weaknesses
Table 145. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 146. AstraZeneca Plc Major Business
Table 147. AstraZeneca Plc Adult Vaccines Product and Services
Table 148. AstraZeneca Plc Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. AstraZeneca Plc Recent Developments/Updates
Table 150. AstraZeneca Plc Competitive Strengths & Weaknesses
Table 151. Medimmune Basic Information, Manufacturing Base and Competitors
Table 152. Medimmune Major Business
Table 153. Medimmune Adult Vaccines Product and Services
Table 154. Medimmune Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Medimmune Recent Developments/Updates
Table 156. Medimmune Competitive Strengths & Weaknesses
Table 157. Sinovac Basic Information, Manufacturing Base and Competitors
Table 158. Sinovac Major Business
Table 159. Sinovac Adult Vaccines Product and Services
Table 160. Sinovac Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Sinovac Recent Developments/Updates
Table 162. Sinovac Competitive Strengths & Weaknesses
Table 163. Baxter International Healthcare Company Basic Information, Manufacturing Base and Competitors
Table 164. Baxter International Healthcare Company Major Business
Table 165. Baxter International Healthcare Company Adult Vaccines Product and Services
Table 166. Baxter International Healthcare Company Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Baxter International Healthcare Company Recent Developments/Updates
Table 168. Baxter International Healthcare Company Competitive Strengths & Weaknesses
Table 169. Chiron Vaccines Basic Information, Manufacturing Base and Competitors
Table 170. Chiron Vaccines Major Business
Table 171. Chiron Vaccines Adult Vaccines Product and Services
Table 172. Chiron Vaccines Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Chiron Vaccines Recent Developments/Updates
Table 174. Serum Institute of India. Basic Information, Manufacturing Base and Competitors
Table 175. Serum Institute of India. Major Business
Table 176. Serum Institute of India. Adult Vaccines Product and Services
Table 177. Serum Institute of India. Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Adult Vaccines Upstream (Raw Materials)
Table 179. Adult Vaccines Typical Customers
Table 180. Adult Vaccines Typical Distributors
List of Figure
Figure 1. Adult Vaccines Picture
Figure 2. World Adult Vaccines Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Adult Vaccines Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Adult Vaccines Production (2018-2029) & (K Units)
Figure 5. World Adult Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 6. World Adult Vaccines Production Value Market Share by Region (2018-2029)
Figure 7. World Adult Vaccines Production Market Share by Region (2018-2029)
Figure 8. North America Adult Vaccines Production (2018-2029) & (K Units)
Figure 9. Europe Adult Vaccines Production (2018-2029) & (K Units)
Figure 10. China Adult Vaccines Production (2018-2029) & (K Units)
Figure 11. Japan Adult Vaccines Production (2018-2029) & (K Units)
Figure 12. Adult Vaccines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 15. World Adult Vaccines Consumption Market Share by Region (2018-2029)
Figure 16. United States Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 17. China Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 18. Europe Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 19. Japan Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 20. South Korea Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 22. India Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Adult Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Adult Vaccines Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Adult Vaccines Markets in 2022
Figure 26. United States VS China: Adult Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Adult Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Adult Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Adult Vaccines Production Market Share 2022
Figure 30. China Based Manufacturers Adult Vaccines Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Adult Vaccines Production Market Share 2022
Figure 32. World Adult Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Adult Vaccines Production Value Market Share by Type in 2022
Figure 34. Monovalent Vaccines
Figure 35. Multivalent Vaccines
Figure 36. World Adult Vaccines Production Market Share by Type (2018-2029)
Figure 37. World Adult Vaccines Production Value Market Share by Type (2018-2029)
Figure 38. World Adult Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Adult Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Adult Vaccines Production Value Market Share by Application in 2022
Figure 41. Private Healthcare Firms
Figure 42. Government Hospitals
Figure 43. World Adult Vaccines Production Market Share by Application (2018-2029)
Figure 44. World Adult Vaccines Production Value Market Share by Application (2018-2029)
Figure 45. World Adult Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Adult Vaccines Industry Chain
Figure 47. Adult Vaccines Procurement Model
Figure 48. Adult Vaccines Sales Model
Figure 49. Adult Vaccines Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World Adult Vaccines Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Adult Vaccines Production Value by Region (2018-2023) & (USD Million)
Table 3. World Adult Vaccines Production Value by Region (2024-2029) & (USD Million)
Table 4. World Adult Vaccines Production Value Market Share by Region (2018-2023)
Table 5. World Adult Vaccines Production Value Market Share by Region (2024-2029)
Table 6. World Adult Vaccines Production by Region (2018-2023) & (K Units)
Table 7. World Adult Vaccines Production by Region (2024-2029) & (K Units)
Table 8. World Adult Vaccines Production Market Share by Region (2018-2023)
Table 9. World Adult Vaccines Production Market Share by Region (2024-2029)
Table 10. World Adult Vaccines Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Adult Vaccines Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Adult Vaccines Major Market Trends
Table 13. World Adult Vaccines Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Adult Vaccines Consumption by Region (2018-2023) & (K Units)
Table 15. World Adult Vaccines Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Adult Vaccines Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Adult Vaccines Producers in 2022
Table 18. World Adult Vaccines Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Adult Vaccines Producers in 2022
Table 20. World Adult Vaccines Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Adult Vaccines Company Evaluation Quadrant
Table 22. World Adult Vaccines Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Adult Vaccines Production Site of Key Manufacturer
Table 24. Adult Vaccines Market: Company Product Type Footprint
Table 25. Adult Vaccines Market: Company Product Application Footprint
Table 26. Adult Vaccines Competitive Factors
Table 27. Adult Vaccines New Entrant and Capacity Expansion Plans
Table 28. Adult Vaccines Mergers & Acquisitions Activity
Table 29. United States VS China Adult Vaccines Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Adult Vaccines Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Adult Vaccines Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Adult Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Adult Vaccines Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Adult Vaccines Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Adult Vaccines Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Adult Vaccines Production Market Share (2018-2023)
Table 37. China Based Adult Vaccines Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Adult Vaccines Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Adult Vaccines Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Adult Vaccines Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Adult Vaccines Production Market Share (2018-2023)
Table 42. Rest of World Based Adult Vaccines Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Adult Vaccines Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Adult Vaccines Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Adult Vaccines Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Adult Vaccines Production Market Share (2018-2023)
Table 47. World Adult Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Adult Vaccines Production by Type (2018-2023) & (K Units)
Table 49. World Adult Vaccines Production by Type (2024-2029) & (K Units)
Table 50. World Adult Vaccines Production Value by Type (2018-2023) & (USD Million)
Table 51. World Adult Vaccines Production Value by Type (2024-2029) & (USD Million)
Table 52. World Adult Vaccines Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Adult Vaccines Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Adult Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Adult Vaccines Production by Application (2018-2023) & (K Units)
Table 56. World Adult Vaccines Production by Application (2024-2029) & (K Units)
Table 57. World Adult Vaccines Production Value by Application (2018-2023) & (USD Million)
Table 58. World Adult Vaccines Production Value by Application (2024-2029) & (USD Million)
Table 59. World Adult Vaccines Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Adult Vaccines Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Solvay Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 62. Solvay Pharmaceuticals Major Business
Table 63. Solvay Pharmaceuticals Adult Vaccines Product and Services
Table 64. Solvay Pharmaceuticals Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Solvay Pharmaceuticals Recent Developments/Updates
Table 66. Solvay Pharmaceuticals Competitive Strengths & Weaknesses
Table 67. Moderna Basic Information, Manufacturing Base and Competitors
Table 68. Moderna Major Business
Table 69. Moderna Adult Vaccines Product and Services
Table 70. Moderna Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Moderna Recent Developments/Updates
Table 72. Moderna Competitive Strengths & Weaknesses
Table 73. BioCSL (Seqirus) Basic Information, Manufacturing Base and Competitors
Table 74. BioCSL (Seqirus) Major Business
Table 75. BioCSL (Seqirus) Adult Vaccines Product and Services
Table 76. BioCSL (Seqirus) Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. BioCSL (Seqirus) Recent Developments/Updates
Table 78. BioCSL (Seqirus) Competitive Strengths & Weaknesses
Table 79. Aventis Pasteur Basic Information, Manufacturing Base and Competitors
Table 80. Aventis Pasteur Major Business
Table 81. Aventis Pasteur Adult Vaccines Product and Services
Table 82. Aventis Pasteur Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Aventis Pasteur Recent Developments/Updates
Table 84. Aventis Pasteur Competitive Strengths & Weaknesses
Table 85. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 86. Sanofi Pasteur Major Business
Table 87. Sanofi Pasteur Adult Vaccines Product and Services
Table 88. Sanofi Pasteur Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Sanofi Pasteur Recent Developments/Updates
Table 90. Sanofi Pasteur Competitive Strengths & Weaknesses
Table 91. Pfizer Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Pfizer Inc. Major Business
Table 93. Pfizer Inc. Adult Vaccines Product and Services
Table 94. Pfizer Inc. Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Pfizer Inc. Recent Developments/Updates
Table 96. Pfizer Inc. Competitive Strengths & Weaknesses
Table 97. Merck & Co. Inc. Basic Information, Manufacturing Base and Competitors
Table 98. Merck & Co. Inc. Major Business
Table 99. Merck & Co. Inc. Adult Vaccines Product and Services
Table 100. Merck & Co. Inc. Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck & Co. Inc. Recent Developments/Updates
Table 102. Merck & Co. Inc. Competitive Strengths & Weaknesses
Table 103. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 104. GlaxoSmithKline Plc Major Business
Table 105. GlaxoSmithKline Plc Adult Vaccines Product and Services
Table 106. GlaxoSmithKline Plc Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. GlaxoSmithKline Plc Recent Developments/Updates
Table 108. GlaxoSmithKline Plc Competitive Strengths & Weaknesses
Table 109. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 110. Novartis AG Major Business
Table 111. Novartis AG Adult Vaccines Product and Services
Table 112. Novartis AG Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Novartis AG Recent Developments/Updates
Table 114. Novartis AG Competitive Strengths & Weaknesses
Table 115. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 116. Johnson & Johnson Major Business
Table 117. Johnson & Johnson Adult Vaccines Product and Services
Table 118. Johnson & Johnson Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Johnson & Johnson Recent Developments/Updates
Table 120. Johnson & Johnson Competitive Strengths & Weaknesses
Table 121. BioNTech Basic Information, Manufacturing Base and Competitors
Table 122. BioNTech Major Business
Table 123. BioNTech Adult Vaccines Product and Services
Table 124. BioNTech Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. BioNTech Recent Developments/Updates
Table 126. BioNTech Competitive Strengths & Weaknesses
Table 127. Bharat Biotech International Limited Basic Information, Manufacturing Base and Competitors
Table 128. Bharat Biotech International Limited Major Business
Table 129. Bharat Biotech International Limited Adult Vaccines Product and Services
Table 130. Bharat Biotech International Limited Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Bharat Biotech International Limited Recent Developments/Updates
Table 132. Bharat Biotech International Limited Competitive Strengths & Weaknesses
Table 133. Zhifei Basic Information, Manufacturing Base and Competitors
Table 134. Zhifei Major Business
Table 135. Zhifei Adult Vaccines Product and Services
Table 136. Zhifei Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Zhifei Recent Developments/Updates
Table 138. Zhifei Competitive Strengths & Weaknesses
Table 139. Wyeth Vaccines Basic Information, Manufacturing Base and Competitors
Table 140. Wyeth Vaccines Major Business
Table 141. Wyeth Vaccines Adult Vaccines Product and Services
Table 142. Wyeth Vaccines Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Wyeth Vaccines Recent Developments/Updates
Table 144. Wyeth Vaccines Competitive Strengths & Weaknesses
Table 145. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 146. AstraZeneca Plc Major Business
Table 147. AstraZeneca Plc Adult Vaccines Product and Services
Table 148. AstraZeneca Plc Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. AstraZeneca Plc Recent Developments/Updates
Table 150. AstraZeneca Plc Competitive Strengths & Weaknesses
Table 151. Medimmune Basic Information, Manufacturing Base and Competitors
Table 152. Medimmune Major Business
Table 153. Medimmune Adult Vaccines Product and Services
Table 154. Medimmune Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Medimmune Recent Developments/Updates
Table 156. Medimmune Competitive Strengths & Weaknesses
Table 157. Sinovac Basic Information, Manufacturing Base and Competitors
Table 158. Sinovac Major Business
Table 159. Sinovac Adult Vaccines Product and Services
Table 160. Sinovac Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. Sinovac Recent Developments/Updates
Table 162. Sinovac Competitive Strengths & Weaknesses
Table 163. Baxter International Healthcare Company Basic Information, Manufacturing Base and Competitors
Table 164. Baxter International Healthcare Company Major Business
Table 165. Baxter International Healthcare Company Adult Vaccines Product and Services
Table 166. Baxter International Healthcare Company Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. Baxter International Healthcare Company Recent Developments/Updates
Table 168. Baxter International Healthcare Company Competitive Strengths & Weaknesses
Table 169. Chiron Vaccines Basic Information, Manufacturing Base and Competitors
Table 170. Chiron Vaccines Major Business
Table 171. Chiron Vaccines Adult Vaccines Product and Services
Table 172. Chiron Vaccines Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Chiron Vaccines Recent Developments/Updates
Table 174. Serum Institute of India. Basic Information, Manufacturing Base and Competitors
Table 175. Serum Institute of India. Major Business
Table 176. Serum Institute of India. Adult Vaccines Product and Services
Table 177. Serum Institute of India. Adult Vaccines Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 178. Global Key Players of Adult Vaccines Upstream (Raw Materials)
Table 179. Adult Vaccines Typical Customers
Table 180. Adult Vaccines Typical Distributors
List of Figure
Figure 1. Adult Vaccines Picture
Figure 2. World Adult Vaccines Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Adult Vaccines Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Adult Vaccines Production (2018-2029) & (K Units)
Figure 5. World Adult Vaccines Average Price (2018-2029) & (US$/Unit)
Figure 6. World Adult Vaccines Production Value Market Share by Region (2018-2029)
Figure 7. World Adult Vaccines Production Market Share by Region (2018-2029)
Figure 8. North America Adult Vaccines Production (2018-2029) & (K Units)
Figure 9. Europe Adult Vaccines Production (2018-2029) & (K Units)
Figure 10. China Adult Vaccines Production (2018-2029) & (K Units)
Figure 11. Japan Adult Vaccines Production (2018-2029) & (K Units)
Figure 12. Adult Vaccines Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 15. World Adult Vaccines Consumption Market Share by Region (2018-2029)
Figure 16. United States Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 17. China Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 18. Europe Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 19. Japan Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 20. South Korea Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 22. India Adult Vaccines Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Adult Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Adult Vaccines Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Adult Vaccines Markets in 2022
Figure 26. United States VS China: Adult Vaccines Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Adult Vaccines Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Adult Vaccines Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Adult Vaccines Production Market Share 2022
Figure 30. China Based Manufacturers Adult Vaccines Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Adult Vaccines Production Market Share 2022
Figure 32. World Adult Vaccines Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Adult Vaccines Production Value Market Share by Type in 2022
Figure 34. Monovalent Vaccines
Figure 35. Multivalent Vaccines
Figure 36. World Adult Vaccines Production Market Share by Type (2018-2029)
Figure 37. World Adult Vaccines Production Value Market Share by Type (2018-2029)
Figure 38. World Adult Vaccines Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Adult Vaccines Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Adult Vaccines Production Value Market Share by Application in 2022
Figure 41. Private Healthcare Firms
Figure 42. Government Hospitals
Figure 43. World Adult Vaccines Production Market Share by Application (2018-2029)
Figure 44. World Adult Vaccines Production Value Market Share by Application (2018-2029)
Figure 45. World Adult Vaccines Average Price by Application (2018-2029) & (US$/Unit)
Figure 46. Adult Vaccines Industry Chain
Figure 47. Adult Vaccines Procurement Model
Figure 48. Adult Vaccines Sales Model
Figure 49. Adult Vaccines Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
